691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation

A.M. Schram; G. Lopes; A.B. El-Khoueiry; E. Fontana; T.B. Karasic; S. Kummar; P. Lorusso; V. Gregorc; M. Millward; S. Ponce Aix; D.L. Richardson; D. Roda Perez; A.I. Spira; D.S. Tan; J.A. Thompson; D. Uprety; M. Fellous; Y.G. Qin; E.E. Dumbrava

Journal ArticleOPEN ACCESS

691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation

Schram A
Lopes G
El-Khoueiry A
et al.

Annals of Oncology (2024) 35 S535-S536

DOI: 10.1016/j.annonc.2024.08.2162

N/ACitations

3Readers

Cite

CITATION STYLE

APA

Schram, A. M., Lopes, G., El-Khoueiry, A. B., Fontana, E., Karasic, T. B., Kummar, S., … Dumbrava, E. E. (2024). 691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation. Annals of Oncology, 35, S535–S536. https://doi.org/10.1016/j.annonc.2024.08.2162

691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation

Cite

Register to see more suggestions